Taken together, we here propose that TSPO expression in GB functions as an adaptive immune resistance mechanism, which is co-regulated with PD-L1 expression through the activity of tumor reactive T cells and accessory inflammatory cells and regulates the sensitivity of GB cells towards TRAIL-mediated apoptosis conferred by cytotoxic T cells. This evidence concerns the gene TNFSF10 and neoplasm.